Tags

Type your tag names separated by a space and hit enter

[Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
Lakartidningen. 2001 Feb 28; 98(9):937-40.L

Abstract

In contrast to fasting glucose, postprandial hyperglycemia in type 2-diabetes has been a relatively neglected area. However, postprandial glucose spikes contribute significantly to overall glycemic control and are strongly correlated with cardiovascular morbidity and mortality (as opposed to fasting glucose). Here we review extant data implicating postprandial hyperglycemia as a tangible target for novel antidiabetic drugs with improved potential to curb not only deleterious glucose excursions, but also the macrovascular complications associated with them.

Authors+Show Affiliations

Karolinska sjukhuset, Stockholm. ake@enk.ks.se

Pub Type(s)

English Abstract
Journal Article
Review

Language

swe

PubMed ID

11292972

Citation

Sjöholm, A. "[Postprandial Hyperglycemia. Cardiovascular Risks and New Therapeutic Strategies]." Lakartidningen, vol. 98, no. 9, 2001, pp. 937-40.
Sjöholm A. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies]. Lakartidningen. 2001;98(9):937-40.
Sjöholm, A. (2001). [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies]. Lakartidningen, 98(9), 937-40.
Sjöholm A. [Postprandial Hyperglycemia. Cardiovascular Risks and New Therapeutic Strategies]. Lakartidningen. 2001 Feb 28;98(9):937-40. PubMed PMID: 11292972.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies]. A1 - Sjöholm,A, PY - 2001/4/11/pubmed PY - 2001/4/21/medline PY - 2001/4/11/entrez SP - 937 EP - 40 JF - Lakartidningen JO - Lakartidningen VL - 98 IS - 9 N2 - In contrast to fasting glucose, postprandial hyperglycemia in type 2-diabetes has been a relatively neglected area. However, postprandial glucose spikes contribute significantly to overall glycemic control and are strongly correlated with cardiovascular morbidity and mortality (as opposed to fasting glucose). Here we review extant data implicating postprandial hyperglycemia as a tangible target for novel antidiabetic drugs with improved potential to curb not only deleterious glucose excursions, but also the macrovascular complications associated with them. SN - 0023-7205 UR - https://www.unboundmedicine.com/medline/citation/11292972/[Postprandial_hyperglycemia__Cardiovascular_risks_and_new_therapeutic_strategies]_ L2 - https://medlineplus.gov/hyperglycemia.html DB - PRIME DP - Unbound Medicine ER -